Peptide-functionalized quantum dots for potential applications in the imaging and treatment of obesity.
Ntevheleni Thovhogi,Nicole Remaliah Samantha Sibuyi,Martin O. Onani,Mervin Meyer,Abram M. Madiehe +4 more
TL;DR: This nanotechnology-based approach could potentially be used for dual targeted drug delivery and molecular imaging of adipose tissues in obese patients in real time.
read more
Abstract: Background Obesity is a worldwide epidemic affecting millions of people. The current pharmacological treatment of obesity remains limited and ineffective due to drugs' undesirable side effects. Hence, there is a need for novel or improved strategies for long-term therapies that will help prevent the disease progression into other chronic diseases. Nanotechnology holds the future for the treatment of obesity because of its versatility, as shown by improved drug efficiency and safety in cancer clinical trials. Nano-based drug delivery systems could potentially do the same for obesity through targeted drug delivery. This study investigated the use of peptide-functionalized quantum dots (QDs) for the imaging of prohibitin (PHB)-expressing cells in vitro and in diet-induced obese rats, which could potentially be used as nanocarriers of antiobesity drugs. Methods Cadmium (Cd)-based QDs were functionalized with an adipose homing peptide (AHP) and injected intravenously into lean and obese Wistar rats. Biodistribution of the QDs was analyzed by an IVIS® Lumina XR imaging system and inductively coupled plasma optical emission spectroscopy (ICP-OES). For in vitro studies, PHB-expressing (Caco-2 and MCF-7) and non-PHB-expressing (KMST-6 and CHO) cells were exposed to either unfunctionalized QDs (QD625) or AHP-functionalized QDs (AHP-QD625) and analyzed by fluorescence microscopy. Results AHP-QD625 accumulated significantly in PHB-expressing cells in vitro when compared with non-PHB-expressing cells. In vivo data indicated that QD625 accumulated mainly in the reticuloendothelial system (RES) organs, while the AHP-QD625 accumulated mostly in the white adipose tissues (WATs). Conclusion AHP-functionalized QDs were successfully and selectively delivered to the PHB-expressing cells in vitro (Caco-2 and MCF-7 cells) and in the WAT vasculature in vivo. This nanotechnology-based approach could potentially be used for dual targeted drug delivery and molecular imaging of adipose tissues in obese patients in real time.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
TL;DR: In this article, a review of nanocarrier-based composites in terms of their structure, characteristics, and therapeutic applications in oncology is presented, and the challenges and future exploration opportunities of Nanocarriers in chemotherapeutics are also presented.
High-quality quantum dots for multiplexed bioimaging: A critical review.
TL;DR: This review summarizes the desirable properties and synthesis methods of such superior QDs followed by their application in multiplexed imaging.
138
Biological Applications and Toxicity Minimization of Semiconductor Quantum Dots.
TL;DR: Approaches to minimize their toxicities according to the specific cell type, organ, or animal species are described, summarizing recent promising research at the cellular, organs, and whole-organism level.
81
Nanotechnology advances towards development of targeted-treatment for obesity
Nicole Remaliah Samantha Sibuyi,Koena Leah Moabelo,Mervin Meyer,Martin O. Onani,Admire Dube,Abram M. Madiehe +5 more
TL;DR: Three nanotechnology-based anti-obesity strategies that target the white adipose tissues (WATs) and its vasculature for the reversal of obesity are presented, providing a proof of concept that targeted nanotherapy can be a feasible strategy that can combat obesity and prevent its comorbidities.
Adiponectin Synthesis, Secretion and Extravasation from Circulation to Interstitial Space
TL;DR: In this article, the authors summarize the current understanding on adiponectin action in its various target tissues and in cellular models and discuss some potential therapeutic approaches using adipogen as a target and the current challenges facing adipogen-based therapeutic interventions.
50
References
Renal clearance of quantum dots.
Hak Soo Choi,Wenhao Liu,Preeti Misra,Eiichi Tanaka,John P. Zimmer,Binil Itty Ipe,Moungi G. Bawendi,John V. Frangioni,John V. Frangioni +8 more
TL;DR: This study has precisely defined the requirements for renal filtration and urinary excretion of inorganic, metal-containing nanoparticles and provides a foundation for the design and development of biologically targeted nanoparticles for biomedical applications.
Dynamics of fat cell turnover in humans
Kirsty L. Spalding,Erik Arner,Pål O. Westermark,Samuel Bernard,Bruce A. Buchholz,Olaf Bergmann,Lennart Blomqvist,Johan Hoffstedt,Erik Näslund,Tom Britton,Hernan Concha,Moustapha Hassan,Mikael Rydén,Jonas Frisén,Peter Arner +14 more
TL;DR: It is shown that adipocyte number is a major determinant for the fat mass in adults, however, the number of fat cells stays constant in adulthood in lean and obese individuals, even after marked weight loss, indicating that thenumber of adipocytes is set during childhood and adolescence.
2.3K
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.
Daniel Bobo,Kye J. Robinson,Jiaul Islam,Jiaul Islam,Kristofer J. Thurecht,Simon R. Corrie,Simon R. Corrie +6 more
TL;DR: An up to date snapshot of nanomedicines either currently approved by the US FDA, or in the FDA clinical trials process is provided, and there is a trend towards the development of more complex materials comprising micelles, protein-based NPs, and also the emergence of a variety of inorganic and metallic particles in clinical trials.
2.2K
Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size
TL;DR: Tissue distribution of gold nanoparticles is size-dependent with the smallest 15 nm nanoparticles showing the most widespread organ distribution.
1K
Adipose tissue mass can be regulated through the vasculature
Maria Rupnick,Dipak Panigrahy,Chen-Yu Zhang,Susan M. Dallabrida,Bradford B. Lowell,Robert Langer,M. Judah Folkman +6 more
TL;DR: It is concluded that adipose tissue mass is sensitive to angiogenesis inhibitors and can be regulated by its vasculature, which is associated with anti-angiogenic weight loss.
971